Atlas Trials

Effect of EPA-DHA Supplement, Life Style Modification Standard Treatment on Clinical Outcome Lipid Membrane Composition in Type 2 Diabetes

Clinical trial NCT02705430 · UNKNOWN

Trial details

NCT number
NCT02705430
Sponsor
Rabin Medical Center
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2018-06-20
Primary completion
2019-03-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.